Atopia Therapeutics
Jacques Billy is an accomplished finance professional with extensive experience in leadership roles across multiple organizations. Currently serving as Managing Partner at Finalta Sàrl and CFO at HpVac, Jacques Billy also holds positions on various advisory and board roles, including advisory board member at FinMetrics and non-executive director at Polytech Ventures. With a background in managing financial operations, Jacques Billy was previously CFO at Veolis and senior partner at Treasury Management SA. Jacques Billy's educational credentials include a Master's degree in International Management and Finance from HEC Paris and a distinguished Baccalaureat C in Maths & Physics from Lycée Jules Verne.
This person is not in any teams
Atopia Therapeutics
Atopia Therapeutics is focused on the development of a preventive and therapeutic first-line therapy against asthma, eczema, food allergies and related allergic diseases.